NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
51 hedge funds and large institutions have $365M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
5% less capital invested
Capital invested by funds: $382M → $365M (-$17.3M)
Holders
51
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$6.55M | |
| 2 | +$4.62M | |
| 3 | +$2.63M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$763K |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$621K |
Top Sellers
| 1 | -$6.9M | |
| 2 | -$4.64M | |
| 3 | -$1.73M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$1.46M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$805K |